• 1
    Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002; 64: 5260.
  • 2
    Chapman DP, Perry GS, Strine TW. The vital link between chronic disease and depressive disorders. Prev Chronic Dis 2005; 2: A14.
  • 3
    Noel PH, Williams JW Jr, Unutzer J, Worchel J, Lee S, Cornell J, et al. Depression and comorbid illness in elderly primary care patients: impact on multiple domains of health status and well-being. Ann Fam Med 2004; 2: 55562.
  • 4
    Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 1997; 13: 11637.
  • 5
    Evers AW, Kraaimaat FW, Geenen R, Bijlsma JW. Determinants of psychological distress and its course in the first year after diagnosis in rheumatoid arthritis patients. J Behav Med 1997; 20: 489504.
  • 6
    Kendler KS, Kessler RC, Neale MC, Heath AC, Eaves LJ. The prediction of major depression in women: toward an integrated etiologic model. Am J Psychiatry 1993; 150: 113948.
  • 7
    Kendler KS, Gardner CO, Prescott CA. Clinical characteristics of major depression that predict risk of depression in relatives. Arch Gen Psychiatry 1999; 56: 3227.
  • 8
    Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol Psychol 2001; 57: 14152.
  • 9
    Royston P, Sauerbrei W. Multivariable model-building: a pragmatic approach to regression analysis based on fractional polynomials for modeling continuous variables. Hoboken (NJ): John Wiley & Sons; 2008.
  • 10
    Breiman L. Statistical modeling: the two cultures. Stat Sci 2001; 16: 199231.
  • 11
    Breiman L. Random forests. Mach Learn 2001; 45: 532.
  • 12
    Wolfe F, Michaud K. A brief introduction to the National Data Bank for Rheumatic Diseases. Clin Exp Rheumatol 2005; 23: S16871.
  • 13
    Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum 2007; 56: 288695.
  • 14
    Nadareishvili Z, Michaud K, Hallenbeck JM, Wolfe F. Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case–control study. Arthritis Rheum 2008; 59: 10906.
  • 15
    Wolfe F, Michaud K. Prevalence, risk, and risk factors for oral and ocular dryness with particular emphasis on rheumatoid arthritis. J Rheumatol 2008; 35: 102330.
  • 16
    Wolfe F, Allaire S, Michaud K. The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability. J Rheumatol 2007; 34: 22117.
  • 17
    Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988; 26: 72435.
  • 18
    Michaud K, Wolfe F. The development of a rheumatic disease research comorbidity index for use in outpatients patients with RA, OA, SLE and fibromyalgia (FMS) [abstract]. Arthritis Rheum 2007; 56 Suppl: S596.
  • 19
    Michaud K, Wolfe F. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007; 21: 885906.
  • 20
    Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 21
    Wolfe F. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum 2000; 43: 275161.
  • 22
    Wolfe F, Michaud K, Pincus T. A composite disease activity scale for clinical practice, observational studies and clinical trials: the Patient Activity Scale (PAS/PAS-II). J Rheumatol 2005; 32: 24105.
  • 23
    Wolfe F. Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease. J Rheumatol 2003; 30: 36978.
  • 24
    Wolfe F, Rasker JJ. The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms. J Rheumatol 2006; 33: 22919.
  • 25
    Doody MM, Hayes HM, Bilgrad R. Comparability of national death index plus and standard procedures for determining causes of death in epidemiologic studies. Ann Epidemiol 2001; 11: 4650.
  • 26
    Berk RA. Data mining within a regression framework. In: MaimonO, RokachL, editors. Data mining and knowledge discovery handbook. New York: Springer; 2005. p. 23155.
  • 27
    Atkinson EJ, Therneau TM. An introduction to recursive partitioning using the RPART routines. Rochester (NY): Mayo Foundation; 2000.
  • 28
    Stata Corporation. Stata statistical software: release 10.0. College Station (TX): Stata Corporation; 2007.
  • 29
    The R Development Core Team. R: a language and environment for statistical computing. Version 2.7.1. Vienna: R Foundation for Statistical Computing; 2008.
  • 30
    Katz PP, Yelin EH. Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J Rheumatol 1993; 20: 7906.
  • 31
    Zung WW, Broadhead WE, Roth ME. Prevalence of depressive symptoms in primary care. J Fam Pract 1993; 37: 33744.
  • 32
    Stallones L, Marx MB, Garrity TF. Prevalence and correlates of depressive symptoms among older U.S. adults. Am J Prev Med 1990; 6: 295303.
  • 33
    Chochinov HM, Wilson KG, Enns M, Lander S. “Are you depressed?” Screening for depression in the terminally ill. Am J Psychiatry 1997; 154: 6746.
  • 34
    Mohr DC, Hart SL, Julian L, Tasch ES. Screening for depression among patients with multiple sclerosis: two questions may be enough. Mult Scler 2007; 13: 2159.
  • 35
    Corson K, Gerrity MS, Dobscha SK. Screening for depression and suicidality in a VA primary care setting: 2 items are better than 1 item. Am J Manag Care 2004; 10: 83945.
  • 36
    Avasarala JR, Cross AH, Trinkaus K. Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis. Mult Scler 2003; 9: 30710.
  • 37
    Beck AT. Depression inventory. Philadelphia: Center for Cognitive Therapy; 1978.
  • 38
    Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol 2004; 31: 695700.
  • 39
    Wolfe F, Michaud K, Choi HK, Williams R. Household income and earnings losses among 6,396 persons with rheumatoid arthritis. J Rheumatol 2005; 32: 187583.
  • 40
    Jackson-Triche ME, Greer Sullivan J, Wells KB, Rogers W, Camp P, Mazel R. Depression and health-related quality of life in ethnic minorities seeking care in general medical settings. J Affect Disord 2000; 58: 8997.
  • 41
    Fifield J, Tennen H, Reisine S, McQuillan J. Depression and the long-term risk of pain, fatigue, and disability in patients with rheumatoid arthritis. Arthritis Rheum 1998; 41: 18517.